Dec 01, 2022 / 04:20PM GMT
Elizabeth Hammell Anderson - Evercore ISI Institutional Equities, Research Division - MD & Fundamental Research Analyst
Hi, everybody. Thanks for joining us this morning. I'm Elizabeth Anderson. I'm the health care technology and distribution analyst here at Evercore. And I'm very excited to be joined by CEO, Stanley Bergman; CFO, Ron South; and VP of Investor Relations and Strategic Finance Project Officer, Graham Stanley, all from Henry Schein. But I imagine you all know that since you click down the Henry Schein link. So we're very excited to chat through things. (Operator Instructions)
Stanley, I don't know if you had any couple of intro remarks that you wanted to make or I can jump straight into the questions.
Stanley M. Bergman - Henry Schein, Inc. - Executive Chairman & CEO
Elizabeth, feel free to ask questions, but I think the track record of Henry Schein, 28 years, public company, compounded annual EPS growth of about 12% for that period of time.
And since we've been public and we grow top line, we grow operating income, we
Henry Schein Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot